{"entity":{"type":"insider","cik":"0001347039","url":"/insider/0001347039","json_url":"/insider/0001347039.json","name":"Xmark Opportunity Partners, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":189,"n_filings":81,"first":"2006-04-14","last":"2013-02-21","span_basis":"filed_date"},"name_variants":[{"name":"Xmark Opportunity Partners, LLC","source":"filing","n_filings":81,"first_seen":"2006-04-14","last_seen":"2013-02-21"}],"transactions":[{"id":5056883,"accession":"0001140361-13-008801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-008801","line_url":"/filing/0001140361-13-008801#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1793894.0,"shares_display":"1,793,894","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":591985.02,"total_display":"591,985.02","total_whole":"591,985","shares_owned_after":96931944.0,"shares_owned_after_display":"96,931,944","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-19","filed_date":"2013-02-21","scope":"insider"},{"id":7404920,"accession":"0001144204-10-044301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-10-044301","line_url":"/filing/0001144204-10-044301#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500000.0,"shares_display":"2,500,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":34415876.0,"shares_owned_after_display":"34,415,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-11","filed_date":"2010-08-16","scope":"insider"},{"id":9274472,"accession":"0001223692-09-000041","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001223692-09-000041","line_url":"/filing/0001223692-09-000041#line-6","is_derivative":false,"issuer_cik":"0001347039","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001347039","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.475,"price_display":"0.48","price_state":"stated","total_value":4750.0,"total_display":"4,750.00","total_whole":"4,750","shares_owned_after":26023019.0,"shares_owned_after_display":"26,023,019","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-28","filed_date":"2009-12-29","scope":"insider"},{"id":9274467,"accession":"0001223692-09-000041","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001223692-09-000041","line_url":"/filing/0001223692-09-000041#line-5","is_derivative":false,"issuer_cik":"0001347039","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001347039","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":4300.0,"total_display":"4,300.00","total_whole":"4,300","shares_owned_after":25298733.0,"shares_owned_after_display":"25,298,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-29","scope":"insider"},{"id":9274468,"accession":"0001223692-09-000041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001223692-09-000041","line_url":"/filing/0001223692-09-000041#line-4","is_derivative":false,"issuer_cik":"0001347039","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001347039","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.415,"price_display":"0.42","price_state":"stated","total_value":4150.0,"total_display":"4,150.00","total_whole":"4,150","shares_owned_after":25288733.0,"shares_owned_after_display":"25,288,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-22","filed_date":"2009-12-29","scope":"insider"},{"id":9274469,"accession":"0001223692-09-000041","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001223692-09-000041","line_url":"/filing/0001223692-09-000041#line-3","is_derivative":false,"issuer_cik":"0001347039","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001347039","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4338,"price_display":"0.43","price_state":"stated","total_value":4338.0,"total_display":"4,338.00","total_whole":"4,338","shares_owned_after":25278733.0,"shares_owned_after_display":"25,278,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-21","filed_date":"2009-12-29","scope":"insider"},{"id":9274470,"accession":"0001223692-09-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-09-000041","line_url":"/filing/0001223692-09-000041#line-2","is_derivative":false,"issuer_cik":"0001347039","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001347039","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.3825,"price_display":"0.38","price_state":"stated","total_value":3825.0,"total_display":"3,825.00","total_whole":"3,825","shares_owned_after":25268733.0,"shares_owned_after_display":"25,268,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-18","filed_date":"2009-12-29","scope":"insider"},{"id":9274471,"accession":"0001223692-09-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-09-000041","line_url":"/filing/0001223692-09-000041#line-1","is_derivative":false,"issuer_cik":"0001347039","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001347039","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.3538,"price_display":"0.35","price_state":"stated","total_value":7076.0,"total_display":"7,076.00","total_whole":"7,076","shares_owned_after":25258733.0,"shares_owned_after_display":"25,258,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-17","filed_date":"2009-12-29","scope":"insider"},{"id":5675412,"accession":"0001223692-09-000032","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001223692-09-000032","line_url":"/filing/0001223692-09-000032#line-6","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5892857.0,"shares_display":"5,892,857","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1649999.96,"total_display":"1,649,999.96","total_whole":"1,650,000","shares_owned_after":22344597.0,"shares_owned_after_display":"22,344,597","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-10-06","filed_date":"2009-10-20","scope":"insider"},{"id":5604263,"accession":"0001005477-09-003142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-09-003142","line_url":"/filing/0001005477-09-003142#line-1","is_derivative":false,"issuer_cik":"0000880431","issuer_name":"GENAERA CORP","issuer_ticker":"GENR","issuer_name_source":null,"issuer_url":"/issuer/0000880431","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.002","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42571.0,"shares_display":"42,571","price_per_share":0.1015,"price_display":"0.10","price_state":"stated","total_value":4320.9565,"total_display":"4,320.96","total_whole":"4,321","shares_owned_after":2795781.0,"shares_owned_after_display":"2,795,781","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-06-29","filed_date":"2009-07-01","scope":"insider"},{"id":5657633,"accession":"0001144204-09-031771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-031771","line_url":"/filing/0001144204-09-031771#line-1","is_derivative":false,"issuer_cik":"0000880431","issuer_name":"GENAERA CORP","issuer_ticker":"GENR","issuer_name_source":null,"issuer_url":"/issuer/0000880431","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.002","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1378723.0,"shares_display":"1,378,723","price_per_share":0.3095,"price_display":"0.31","price_state":"stated","total_value":426714.7685,"total_display":"426,714.77","total_whole":"426,715","shares_owned_after":2838352.0,"shares_owned_after_display":"2,838,352","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-06-05","filed_date":"2009-06-09","scope":"insider"},{"id":5675408,"accession":"0001223692-09-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-09-000032","line_url":"/filing/0001223692-09-000032#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":7800.0,"total_display":"7,800.00","total_whole":"7,800","shares_owned_after":16356203.0,"shares_owned_after_display":"16,356,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-22","filed_date":"2009-10-20","scope":"insider"},{"id":5675407,"accession":"0001223692-09-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-09-000032","line_url":"/filing/0001223692-09-000032#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.3925,"price_display":"0.39","price_state":"stated","total_value":7850.0,"total_display":"7,850.00","total_whole":"7,850","shares_owned_after":16336203.0,"shares_owned_after_display":"16,336,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-02","filed_date":"2009-10-20","scope":"insider"},{"id":9274437,"accession":"0001223692-09-000013","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-18","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5357143.0,"shares_display":"5,357,143","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1500000.04,"total_display":"1,500,000.04","total_whole":"1,500,000","shares_owned_after":16316203.0,"shares_owned_after_display":"16,316,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-30","filed_date":"2009-04-20","scope":"insider"},{"id":5638277,"accession":"0001223692-09-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-09-000011","line_url":"/filing/0001223692-09-000011#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5357143.0,"shares_display":"5,357,143","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1500000.04,"total_display":"1,500,000.04","total_whole":"1,500,000","shares_owned_after":16186203.0,"shares_owned_after_display":"16,186,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-30","filed_date":"2009-04-02","scope":"insider"},{"id":9274438,"accession":"0001223692-09-000013","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-17","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.4175,"price_display":"0.42","price_state":"stated","total_value":8350.0,"total_display":"8,350.00","total_whole":"8,350","shares_owned_after":10959060.0,"shares_owned_after_display":"10,959,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-24","filed_date":"2009-04-20","scope":"insider"},{"id":9274439,"accession":"0001223692-09-000013","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-16","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":10939060.0,"shares_owned_after_display":"10,939,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-11","filed_date":"2009-04-20","scope":"insider"},{"id":9274440,"accession":"0001223692-09-000013","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-15","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.4338,"price_display":"0.43","price_state":"stated","total_value":17352.0,"total_display":"17,352.00","total_whole":"17,352","shares_owned_after":10919060.0,"shares_owned_after_display":"10,919,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-10","filed_date":"2009-04-20","scope":"insider"},{"id":9274441,"accession":"0001223692-09-000013","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-14","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":79838.0,"shares_display":"79,838","price_per_share":0.348,"price_display":"0.35","price_state":"stated","total_value":27783.624,"total_display":"27,783.62","total_whole":"27,784","shares_owned_after":10879060.0,"shares_owned_after_display":"10,879,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-31","filed_date":"2009-04-20","scope":"insider"},{"id":5638276,"accession":"0001223692-09-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-09-000011","line_url":"/filing/0001223692-09-000011#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":79838.0,"shares_display":"79,838","price_per_share":0.348,"price_display":"0.35","price_state":"stated","total_value":27783.624,"total_display":"27,783.62","total_whole":"27,784","shares_owned_after":10829060.0,"shares_owned_after_display":"10,829,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-31","filed_date":"2009-04-02","scope":"insider"},{"id":9274442,"accession":"0001223692-09-000013","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-13","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":1750.0,"total_display":"1,750.00","total_whole":"1,750","shares_owned_after":10799222.0,"shares_owned_after_display":"10,799,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-31","filed_date":"2009-04-20","scope":"insider"},{"id":9274443,"accession":"0001223692-09-000013","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-12","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":3200.0,"total_display":"3,200.00","total_whole":"3,200","shares_owned_after":10794222.0,"shares_owned_after_display":"10,794,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-30","filed_date":"2009-04-20","scope":"insider"},{"id":3895697,"accession":"0001223692-08-000026","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001223692-08-000026","line_url":"/filing/0001223692-08-000026#line-6","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":3200.0,"total_display":"3,200.00","total_whole":"3,200","shares_owned_after":10749222.0,"shares_owned_after_display":"10,749,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-30","filed_date":"2008-12-31","scope":"insider"},{"id":9274444,"accession":"0001223692-09-000013","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-11","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":1950.0,"total_display":"1,950.00","total_whole":"1,950","shares_owned_after":10784222.0,"shares_owned_after_display":"10,784,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-29","filed_date":"2009-04-20","scope":"insider"},{"id":9274445,"accession":"0001223692-09-000013","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-10","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7950.0,"shares_display":"7,950","price_per_share":0.3069,"price_display":"0.31","price_state":"stated","total_value":2439.855,"total_display":"2,439.86","total_whole":"2,440","shares_owned_after":10779222.0,"shares_owned_after_display":"10,779,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-26","filed_date":"2009-04-20","scope":"insider"},{"id":9274446,"accession":"0001223692-09-000013","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-9","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":1470.0,"total_display":"1,470.00","total_whole":"1,470","shares_owned_after":10771272.0,"shares_owned_after_display":"10,771,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-24","filed_date":"2009-04-20","scope":"insider"},{"id":9274447,"accession":"0001223692-09-000013","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-8","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":780.0,"total_display":"780.00","total_whole":"780","shares_owned_after":10766372.0,"shares_owned_after_display":"10,766,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-17","filed_date":"2009-04-20","scope":"insider"},{"id":9274431,"accession":"0001223692-09-000013","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-7","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.345,"price_display":"0.34","price_state":"stated","total_value":690.0,"total_display":"690.00","total_whole":"690","shares_owned_after":10764372.0,"shares_owned_after_display":"10,764,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-16","filed_date":"2009-04-20","scope":"insider"},{"id":9274448,"accession":"0001223692-09-000013","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-6","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.345,"price_display":"0.34","price_state":"stated","total_value":3450.0,"total_display":"3,450.00","total_whole":"3,450","shares_owned_after":10762372.0,"shares_owned_after_display":"10,762,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-10","filed_date":"2009-04-20","scope":"insider"},{"id":9274436,"accession":"0001223692-09-000013","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-5","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.3475,"price_display":"0.35","price_state":"stated","total_value":6950.0,"total_display":"6,950.00","total_whole":"6,950","shares_owned_after":10752372.0,"shares_owned_after_display":"10,752,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-28","filed_date":"2009-04-20","scope":"insider"},{"id":9274435,"accession":"0001223692-09-000013","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-4","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.3295,"price_display":"0.33","price_state":"stated","total_value":13180.0,"total_display":"13,180.00","total_whole":"13,180","shares_owned_after":10732372.0,"shares_owned_after_display":"10,732,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-21","filed_date":"2009-04-20","scope":"insider"},{"id":3662304,"accession":"0001223692-08-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-08-000017","line_url":"/filing/0001223692-08-000017#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.3295,"price_display":"0.33","price_state":"stated","total_value":13180.0,"total_display":"13,180.00","total_whole":"13,180","shares_owned_after":10717372.0,"shares_owned_after_display":"10,717,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-21","filed_date":"2008-12-03","scope":"insider"},{"id":9274434,"accession":"0001223692-09-000013","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-3","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":10692372.0,"shares_owned_after_display":"10,692,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-14","filed_date":"2009-04-20","scope":"insider"},{"id":2576660,"accession":"0001223692-08-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-08-000013","line_url":"/filing/0001223692-08-000013#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":10677372.0,"shares_owned_after_display":"10,677,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-14","filed_date":"2008-10-17","scope":"insider"},{"id":9274433,"accession":"0001223692-09-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":6150.0,"total_display":"6,150.00","total_whole":"6,150","shares_owned_after":10677372.0,"shares_owned_after_display":"10,677,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-10","filed_date":"2009-04-20","scope":"insider"},{"id":9274432,"accession":"0001223692-09-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-09-000013","line_url":"/filing/0001223692-09-000013#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.4133,"price_display":"0.41","price_state":"stated","total_value":6199.5,"total_display":"6,199.50","total_whole":"6,200","shares_owned_after":10662372.0,"shares_owned_after_display":"10,662,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-07","filed_date":"2009-04-20","scope":"insider"},{"id":3662302,"accession":"0001223692-08-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001223692-08-000008","line_url":"/filing/0001223692-08-000008#line-3","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.4333,"price_display":"0.43","price_state":"stated","total_value":6499.5,"total_display":"6,499.50","total_whole":"6,500","shares_owned_after":10647372.0,"shares_owned_after_display":"10,647,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-29","filed_date":"2008-10-01","scope":"insider"},{"id":3838339,"accession":"0001223692-08-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001223692-08-000006","line_url":"/filing/0001223692-08-000006#line-4","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":3900.0,"total_display":"3,900.00","total_whole":"3,900","shares_owned_after":10622372.0,"shares_owned_after_display":"10,622,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-18","filed_date":"2008-09-19","scope":"insider"},{"id":2715396,"accession":"0001188112-08-002424","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001188112-08-002424","line_url":"/filing/0001188112-08-002424#line-5","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS.OB","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.4117,"price_display":"0.41","price_state":"stated","total_value":2470.2,"total_display":"2,470.20","total_whole":"2,470","shares_owned_after":10592152.0,"shares_owned_after_display":"10,592,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-18","filed_date":"2008-08-20","scope":"insider"},{"id":2715389,"accession":"0001188112-08-002424","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001188112-08-002424","line_url":"/filing/0001188112-08-002424#line-4","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS.OB","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.4033,"price_display":"0.40","price_state":"stated","total_value":2419.8,"total_display":"2,419.80","total_whole":"2,420","shares_owned_after":10586152.0,"shares_owned_after_display":"10,586,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-08","filed_date":"2008-08-20","scope":"insider"},{"id":2715384,"accession":"0001188112-08-002424","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001188112-08-002424","line_url":"/filing/0001188112-08-002424#line-3","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS.OB","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":80.0,"total_display":"80.00","total_whole":"80","shares_owned_after":10580152.0,"shares_owned_after_display":"10,580,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-07","filed_date":"2008-08-20","scope":"insider"},{"id":2715379,"accession":"0001188112-08-002424","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001188112-08-002424","line_url":"/filing/0001188112-08-002424","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS.OB","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20100.0,"shares_display":"20,100","price_per_share":0.35495373134328356,"price_display":"0.35","price_state":"stated","total_value":7134.57,"total_display":"7,134.57","total_whole":"7,135","shares_owned_after":10579952.0,"shares_owned_after_display":"10,579,952","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-04","filed_date":"2008-08-20","scope":"insider","n_lines":2},{"id":2324852,"accession":"0001005477-08-004444","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-08-004444","line_url":"/filing/0001005477-08-004444#line-2","is_derivative":false,"issuer_cik":"0000880431","issuer_name":"GENAERA CORP","issuer_ticker":"GENR","issuer_name_source":null,"issuer_url":"/issuer/0000880431","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.0788,"price_display":"2.08","price_state":"stated","total_value":31182.0,"total_display":"31,182.00","total_whole":"31,182","shares_owned_after":4217075.0,"shares_owned_after_display":"4,217,075","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-20","filed_date":"2008-06-23","scope":"insider"},{"id":2324799,"accession":"0001005477-08-004444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-08-004444","line_url":"/filing/0001005477-08-004444#line-1","is_derivative":false,"issuer_cik":"0000880431","issuer_name":"GENAERA CORP","issuer_ticker":"GENR","issuer_name_source":null,"issuer_url":"/issuer/0000880431","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.0973,"price_display":"2.10","price_state":"stated","total_value":20973.0,"total_display":"20,973.00","total_whole":"20,973","shares_owned_after":4202075.0,"shares_owned_after_display":"4,202,075","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-23","scope":"insider"},{"id":4008788,"accession":"0001005477-08-004215","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001005477-08-004215","line_url":"/filing/0001005477-08-004215","is_derivative":false,"issuer_cik":"0000880431","issuer_name":"GENAERA CORP","issuer_ticker":"GENR","issuer_name_source":null,"issuer_url":"/issuer/0000880431","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18658.0,"shares_display":"18,658","price_per_share":2.1195723978990246,"price_display":"2.12","price_state":"stated","total_value":39546.9818,"total_display":"39,546.98","total_whole":"39,547","shares_owned_after":4183417.0,"shares_owned_after_display":"4,183,417","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-18","filed_date":"2008-06-19","scope":"insider","n_lines":2},{"id":4008782,"accession":"0001005477-08-004215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-08-004215","line_url":"/filing/0001005477-08-004215#line-1","is_derivative":false,"issuer_cik":"0000880431","issuer_name":"GENAERA CORP","issuer_ticker":"GENR","issuer_name_source":null,"issuer_url":"/issuer/0000880431","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6600.0,"shares_display":"6,600","price_per_share":2.0527,"price_display":"2.05","price_state":"stated","total_value":13547.82,"total_display":"13,547.82","total_whole":"13,548","shares_owned_after":4173417.0,"shares_owned_after_display":"4,173,417","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-17","filed_date":"2008-06-19","scope":"insider"},{"id":3674931,"accession":"0001005477-08-004021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-08-004021","line_url":"/filing/0001005477-08-004021#line-1","is_derivative":false,"issuer_cik":"0000880431","issuer_name":"GENAERA CORP","issuer_ticker":"GENR","issuer_name_source":null,"issuer_url":"/issuer/0000880431","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.222,"price_display":"2.22","price_state":"stated","total_value":33330.0,"total_display":"33,330.00","total_whole":"33,330","shares_owned_after":4166817.0,"shares_owned_after_display":"4,166,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-04","filed_date":"2008-06-06","scope":"insider"},{"id":3815123,"accession":"0001005477-08-003772","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-08-003772","line_url":"/filing/0001005477-08-003772#line-2","is_derivative":false,"issuer_cik":"0000880431","issuer_name":"GENAERA CORP","issuer_ticker":"GENR","issuer_name_source":null,"issuer_url":"/issuer/0000880431","owner_cik":"0001347039","owner_name":"Xmark Opportunity Partners, LLC","owner_display_name":"Xmark Opportunity Partners, LLC","owner_url":"/insider/0001347039","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26700.0,"shares_display":"26,700","price_per_share":1.9457,"price_display":"1.95","price_state":"stated","total_value":51950.19,"total_display":"51,950.19","total_whole":"51,950","shares_owned_after":4151817.0,"shares_owned_after_display":"4,151,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-30","filed_date":"2008-06-02","scope":"insider"}],"collapsed":true,"next_cursor":"2008-05-30|3815123","ledger_fault":false,"count":{"value":183,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":180,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":183},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001261734","name":"AEOLUS PHARMACEUTICALS, INC.","url":"/issuer/0001261734","role":"Ten percent owner","n_filings":39,"first_seen":"2007-04-20","last_seen":"2013-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000880431","name":"GENAERA CORP","url":"/issuer/0000880431","role":"Ten percent owner","n_filings":38,"first_seen":"2007-05-30","last_seen":"2009-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000932352","name":"VALENTIS INC","url":"/issuer/0000932352","role":"Other","n_filings":4,"first_seen":"2006-04-14","last_seen":"2006-04-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001347039","retrieved_at":"2026-08-24T13:32:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}